Aminian A, Wang L, Al Jabri A, Wilson R, Bena J, Milinovich A, Jin J, Heinzinger C, Pena-Orbea C, Foldvary-Schaefer N, Nissen SE, Mehra R (2024) Adverse cardiovascular outcomes in patients with obstructive sleep apnea and obesity: metabolic surgery vs usual care. J Am Coll Cardiol 84:1047–1060

CAS  PubMed  Google Scholar 

Aminian A, Wilson R, Zajichek A, Tu C, Wolski KE, Schauer PR, Kattan MW, Nissen SE, Brethauer SA (2021) Cardiovascular outcomes in patients with type 2 diabetes and obesity: comparison of gastric bypass, sleeve gastrectomy, and usual care. Diab Care 44:2552–2563

CAS  Google Scholar 

Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122(248–256):e245

Google Scholar 

Mian A, Khan S (2023) Systematic review: outcomes of bariatric surgery in patients with inflammatory bowel disease and de-novo IBD development after bariatric surgery. Surgeon 21:e71–e77

PubMed  Google Scholar 

Egeberg A, Sorensen JA, Gislason GH, Knop FK, Skov L (2017) Incidence and prognosis of psoriasis and psoriatic arthritis in patients undergoing bariatric surgery. JAMA Surg 152:344–349

PubMed  Google Scholar 

Singh S, Dulai PS, Zarrinpar A, Ramamoorthy S, Sandborn WJ (2017) Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes. Nat Rev Gastroenterol Hepatol 14:110–121

CAS  PubMed  Google Scholar 

Samad F, Ruf W (2013) Inflammation, obesity, and thrombosis. Blood 122:3415–3422

CAS  PubMed  PubMed Central  Google Scholar 

Mabeza RM, Vadlakonda A, Chervu N, Ebrahimian S, Sakowitz S, Yetasook A, Benharash P (2024) Short-term outcomes of bariatric surgery in patients with inflammatory bowel disease: a national analysis. Surg Obes Relat Dis 20:146–152

PubMed  Google Scholar 

Litmanovich A, Yuval JB, Agostini ED, Orbach L, Kariv Y, Zemel M, Lahat G, Abu-Abeid A (2025) Outcomes of metabolic and bariatric surgery in patients with inflammatory bowel disease: a long-term retrospective analysis. J Clin Med 14:402

CAS  PubMed  PubMed Central  Google Scholar 

Aminian A, Andalib A, Ver MR, Corcelles R, Schauer PR, Brethauer SA (2016) Outcomes of bariatric surgery in patients with inflammatory bowel disease. Obes Surg 26:1186–1190

PubMed  Google Scholar 

Bazerbachi F, Sawas T, Vargas EJ, Haffar S, Deepak P, Kisiel JB, Loftus EV Jr, Abu Dayyeh BK (2018) Bariatric surgery is acceptably safe in obese inflammatory bowel disease patients: analysis of the nationwide inpatient sample. Obes Surg 28:1007–1014

PubMed  Google Scholar 

Hefler J, Dang J, Modasi A, Switzer N, Birch DW, Karmali S (2019) Effects of chronic corticosteroid and immunosuppressant use in patients undergoing bariatric surgery. Obes Surg 29:3309–3315

PubMed  Google Scholar 

Maroun J, Vahibe A, Shah M, Mundi MS, Acosta A, McKenzie TJ, Kellogg TA, Ghanem OM (2023) Impact of chronic immunosuppression on short-, mid-, and long-term bariatric surgery outcomes. Obes Surg 33:240–246

PubMed  Google Scholar 

Manson SC, Brown RE, Cerulli A, Vidaurre CF (2009) The cumulative burden of oral corticosteroid side effects and the economic implications of steroid use. Respir Med 103:975–994

PubMed  Google Scholar 

Rice JB, White AG, Scarpati LM, Wan G, Nelson WW (2017) Long-term systemic corticosteroid exposure: a systematic literature review. Clin Ther 39:2216–2229

CAS  PubMed  Google Scholar 

Subramanian V, Saxena S, Kang JY, Pollok RC (2008) Preoperative steroid use and risk of postoperative complications in patients with inflammatory bowel disease undergoing abdominal surgery. Am J Gastroenterol 103:2373–2381

PubMed  Google Scholar 

Chouairi F, Torabi SJ, Mercier MR, Gabrick KS, Alperovich M (2019) Chronic steroid use as an independent risk factor for perioperative complications. Surgery 165:990–995

PubMed  Google Scholar 

Bakkour W, Purssell H, Chinoy H, Griffiths CE, Warren RB (2016) The risk of post-operative complications in psoriasis and psoriatic arthritis patients on biologic therapy undergoing surgical procedures. J Eur Acad Dermatol Venereol 30:86–91

CAS  PubMed  Google Scholar 

Cohen BL, Fleshner P, Kane SV, Herfarth HH, Palekar N, Farraye FA, Leighton JA, Katz JA, Cohen RD, Gerich ME, Cross RK, Higgins PDR, Tinsley A, Glover S, Siegel CA, Bohl JL, Iskandar H, Ji J, Hu L, Sands BE (2022) Prospective cohort study to investigate the safety of preoperative tumor necrosis factor inhibitor exposure in patients with inflammatory bowel disease undergoing intra-abdominal surgery. Gastroenterology 163:204–221

CAS  PubMed  Google Scholar 

Kuek A, Hazleman BL, Ostor AJ (2007) Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution. Postgrad Med J 83:251–260

CAS  PubMed  PubMed Central  Google Scholar 

Baumgart DC, Le Berre C (2021) Newer biologic and small-molecule therapies for inflammatory bowel disease. N Engl J Med 385:1302–1315

CAS  PubMed  Google Scholar 

Brethauer SA, Kim J, el Chaar M, Papasavas P, Eisenberg D, Rogers A, Ballem N, Kligman M, Kothari S, Committee ACI (2015) Standardized outcomes reporting in metabolic and bariatric surgery. Surg Obes Relat Dis 11:489–506

PubMed  Google Scholar 

Hales CM, Carroll MD, Fryar CD, Ogden CL (2017) Prevalence of obesity among adults and youth: United States, 2015–2016. NCHS Data Brief: 1–8

Kostev K, Madelung M (2019) Prescription-based prevalence of biological therapy in patients with psoriasis, rheumatoid arthritis, and inflammatory bowel diseases. Biologicals 61:52–54

PubMed  Google Scholar 

Johns AJ, Luce MS, Kaneski MJ, Lowery RA, Jachniewicz B, Salas A, McCreary R, Russell RM, Lyo V, Ali MR, Ahmed SM (2023) The long weight: association between distressed communities index and long-term weight outcomes following bariatric surgery. Surg Endosc 37:7218–7225

PubMed  PubMed Central  Google Scholar 

Belle SH, Berk PD, Chapman WH, Christian NJ, Courcoulas AP, Dakin GF, Flum DR, Horlick M, King WC, McCloskey CA, Mitchell JE, Patterson EJ, Pender JR, Steffen KJ, Thirlby RC, Wolfe BM, Yanovski SZ, Consortium L (2013) Baseline characteristics of participants in the Longitudinal Assessment of Bariatric Surgery-2 (LABS-2) study. Surg Obes Relat Dis. 9: 926-935

Sudan R, Maciejewski ML, Wilk AR, Nguyen NT, Ponce J, Morton JM (2017) Comparative effectiveness of primary bariatric operations in the United States. Surg Obes Relat Dis 13:826–834

PubMed  Google Scholar 

Arterburn D, Wellman R, Emiliano A, Smith SR, Odegaard AO, Murali S, Williams N, Coleman KJ, Courcoulas A, Coley RY, Anau J, Pardee R, Toh S, Janning C, Cook A, Sturtevant J, Horgan C, McTigue KM, Collaborative PCBS (2018) Comparative effectiveness and safety of bariatric procedures for weight loss: a PCORnet cohort study. Ann Intern Med 169:741–750

PubMed  PubMed Central  Google Scholar